Antony Koblish
Co-Founder and Former Chief Executive OfficerTELA Bio
Medical DevicesView Profile →Executive Vice President and President, Neuroscience Portfolio · Medtronic
Kweli P. Thompson leads Medtronic's Neuroscience Portfolio. His responsibilities include operating units involved in neurological care, spine surgery, pain management and several adjacent specialties.
Last reviewed: Nov 19, 2026
Kweli P. Thompson leads Medtronic’s Neuroscience Portfolio. His responsibilities include operating units involved in neurological care, spine surgery, pain management and several adjacent specialties.
Thompson trained in medicine, business and public health. His Medtronic career brought together clinical research, product marketing and management of specific medical-device businesses. In global cardiovascular clinical research, he led a collaboration with the FDA, stent makers, pharmaceutical companies and the Harvard Clinical Research Institute to design an international study. He also held clinical affairs and endovascular marketing appointments.
He later led the Cardiac Resynchronization Therapies and Defibrillation Solutions businesses. Those roles preceded his appointment to head Cardiac Rhythm Management, an operating unit concerned with the diagnosis and treatment of heart rhythm disorders.
Medtronic appointed Thompson to lead its Neuroscience Portfolio in June 2026. The move expanded his scope into businesses working with clinicians in movement disorders, neurosurgery, orthopedic surgery and other specialties. He has also served on the board of the Guthrie Theater and previously on the board of the Blake School.
BA, Harvard College; MPH, Harvard T.H. Chan School of Public Health; MBA, Harvard Business School; MD, Harvard Medical School.